EXGLENTRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Jan 2022)
What this means for you
This application is over — abandoned 24 Jan 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88493072
- Mark type
- Stylized text
- Filed
- 28 Jun 2019
- Published for opposition
- 28 Apr 2020
- Abandoned
- 24 Jan 2022
- Attorney of record
- Jenevieve Maerker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, tumors, and oncological diseases and disorders
Owner
- Calithera Biosciences, Inc., South San Francisco, CA, US
- Calithera Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 24 Jan 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Jan 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 25 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2021 — SOU EXTENSION 2 GRANTED
- 21 May 2021 — SOU EXTENSION 2 FILED
- 21 May 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Dec 2020 — SOU EXTENSION 1 GRANTED
- 21 Dec 2020 — SOU EXTENSION 1 FILED
- 21 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 23 Jun 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Apr 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2020 — PUBLISHED FOR OPPOSITION
- 08 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Mar 2020 — ASSIGNED TO LIE